Sentence examples for pathway differences from inspiring English sources

This finding shows that although different diseases are associated with the same signaling pathway, differences in the effects of the stimulated pathways can be induced by complementary expression profiles of microRNAs.

Furthermore, analysis of PBMC proteomics data previously obtained from MDD patients32 identified biological pathway differences between antidepressant responders and non-responders.

However, since our previous studies with the same patient cohorts showed consistent molecular pathway differences between responders and non-responders25,26 non-responders25,26terogeneity in our cohorts may not be critical.

Follow up proteomics analysis in peripheral blood mononuclear cells (PBMCs) collected from MDD patients (n = 20) identified baseline and post-antidepressant treatment pathway differences between responder and non-responder patients.

Even in cases in which a product of catabolism is used in an anabolic pathway, differences emerge; thus, fatty acids, which are catabolized to acetyl coenzyme A, are synthesized not from acetyl coenzyme A directly but from a derivative of it, malonyl coenzyme A (see below Lipid components).

Even in cases in which a product of catabolism is used in an anabolic pathway, differences emerge; thus, fatty acids, which are catabolized to acetyl coenzyme A, are synthesized not from acetyl coenzyme A directly but from a derivative of it, malonyl coenzyme A (see below The biosynthesis of cell components: Lipid components).

Recently, it was understood that quantitative (strength and duration of activities of the pathways) rather than qualitative (e.g. regulation of different pathways) differences between signaling pathways may largely account for dissimilar biological responses [11].

The pathway ACCs of the benchmark classifiers are subtracted from that of BNKL and then Mann-Whitney test is appied on each of the resulting 3 sets of 225 (the number of tested pathways) differences.

These may include different carcinogenic pathways, difference in exposure to risk factors or differential sensitivity to chemotherapy (Iacopetta, 2002).

The observed "pre-" versus "post-pathway" difference would then become confounded by cofactors rather related with the local orthopedic surgeons and their implant preferences than with the underlying pathway proposals.

Similarly, the improvement in dyssynchrony was more marked in patients with nonseptal versus septal pathways (difference between septal and lateral wall motion delay before and after ablation 20.6 ± 7.1 ms (P = 0.015) versus 1.4 ± 11.4 ms (P = 0.655)).